(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 5.54% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Evolent Health's revenue in 2025 is $2,398,737,000.On average, 5 Wall Street analysts forecast EVH's revenue for 2025 to be $241,296,995,085, with the lowest EVH revenue forecast at $235,641,376,638, and the highest EVH revenue forecast at $243,017,606,700. On average, 5 Wall Street analysts forecast EVH's revenue for 2026 to be $283,390,462,161, with the lowest EVH revenue forecast at $265,814,301,806, and the highest EVH revenue forecast at $312,306,974,562.
In 2027, EVH is forecast to generate $332,937,643,173 in revenue, with the lowest revenue forecast at $312,494,814,258 and the highest revenue forecast at $362,788,892,862.